Wikidata

(Q40050028)

English

Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic

scientific article published on 20 November 2007

In more languages

Statements

title
Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
author name string
Stacie J Bell
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
Christine M Fam
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
Elizabeth A Chlipala
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
Sharon J Carlson
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
Ji I Lee
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
Mary S Rosendahl
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
Daniel H Doherty
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
George N Cox
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
publication date
20 November 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017
page(s)
299-305
1 reference
stated in
Europe PubMed Central
PubMed ID
18020402
retrieved
16 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40050028&oldid=1883296792"